发明名称 Cross-protective live attenuated human rotavirus vaccine
摘要 <p>Disclosed is the use of an attenuated rotavirus strain from a G1 serotype in the preparation of a composition for inducing an immune response against rotavirus infection from the G1 and at least two of the non-G1 rotavirus serotypes selected from the group consisting of: G2, G3, G4 and G9 serotypes, wherein the attenuated rotavirus strain is a single rotavirus variant, or substantially a single rotavirus variant, having a VP4 gene comprising, in the nucleotide sequence, an adenine base (A) at positions 788 and 802 and a thymine base (T) at position 501 from the start codon; and wherein the VP7 gene comprises, in the nucleotide sequence, a thymine.</p>
申请公布号 NZ545639(A) 申请公布日期 2009.04.30
申请号 NZ20040545639 申请日期 2004.08.31
申请人 GLAXOSMITHKLINE BIOLOGICALS S.A. 发明人 COLAU, BRIGITTE DESIREE ALBERTE;DE VOS, BEATRICE ARSENE VIRGINIE
分类号 A61K39/15;(IPC1-7):A61K39/15;C12N7/00 主分类号 A61K39/15
代理机构 代理人
主权项
地址